People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Biotech / Pharma, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oncoheroes Biosciences Inc. | — | Biotech / Pharma | Series A | $8.9M | $296.5M | 2018 |
| Rasio Therapeutics, Inc. | — | Biotechnology | Seed | $1.5M | $31.3M | 2021 |
| AngeLink, Inc. | — | Other Technology | Pre-Seed | $300K | $986K | 2025 |
Sujuan Ba at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Sujuan Ba on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Goldberg | 1 | 9 |
| Raju Kucherlapati | 1 | 4 |
| Gabriele Brambilla | 1 | 2 |
| Laura Ariza | 1 | 1 |
| Gerry Poirier | 1 | 1 |
| Markus Rinderer | 1 | 1 |
| Steve Wishner | 1 | 1 |
| Joseph Benaroya | 1 | 1 |
| Ricardo Garcia | 1 | 1 |
| Marco Munoz | 1 | 1 |
| Cesare Spadoni | 1 | 1 |
| Ken Malone | 1 | 1 |
| Sheila Nasehi | 1 | 1 |
| Huijun Yang | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.